Literature DB >> 16139561

The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms.

Jennifer Bolt1, Quynh N Vo, Wan-Ju Kim, Andrew J McWhorter, Jessica Thomson, Michael E Hagensee, Paul Friedlander, Kevin D Brown, Jill Gilbert.   

Abstract

The ATM/p53 pathway plays a critical role in maintenance of genome integrity and can be targeted for inactivation by a number of characterized mechanisms including somatic genetic/epigenetic alterations and expression of oncogenic viral proteins. Here, we examine a panel of 24 SCCHN tumors using various molecular approaches for the presence of human papillomavirus (HPV), mutations in the p53 gene and methylation of the ATM promoter. We observed that 30% of our SCCHN samples displayed the presence of HPV and all but one was HPV type 16. All HPV E6 gene-positive tumors exhibited E6 transcript expression. We observed 21% of the tumors harbored p53 mutations and 42% of tumors displayed ATM promoter methylation. The majority of tumors (71%) were positive for at least one of these events. These findings indicate that molecular events resulting in inactivation of the ATM/p53 pathway are common in SCCHN and can arise by a number of distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139561     DOI: 10.1016/j.oraloncology.2005.06.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  19 in total

1.  Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR.

Authors:  Philip M Reaper; Matthew R Griffiths; Joanna M Long; Jean-Damien Charrier; Somhairle Maccormick; Peter A Charlton; Julian M C Golec; John R Pollard
Journal:  Nat Chem Biol       Date:  2011-04-13       Impact factor: 15.040

2.  PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation.

Authors:  Zhen Xue; Shuang Zheng; Dongli Linghu; Boning Liu; Yi Yang; Mei-Kuang Chen; Hua Huang; Jiaming Song; Hongyue Li; Jing Wang; Mien-Chie Hung; Diansheng Zhong; Linlin Sun
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

3.  Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.

Authors:  Yuxia Cui; Stela S Palii; Cynthia L Innes; Richard S Paules
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  ATM in oral carcinogenesis: association with clinicopathological features.

Authors:  Yuan He; Qianming Chen; Bingqi Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-21       Impact factor: 4.553

5.  The mTOR pathway negatively controls ATM by up-regulating miRNAs.

Authors:  Changxian Shen; Peter J Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

Review 6.  Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.

Authors:  Jennifer L Hunt; Leon Barnes; James S Lewis; Magdy E Mahfouz; Pieter J Slootweg; Lester D R Thompson; Antonio Cardesa; Kenneth O Devaney; Douglas R Gnepp; William H Westra; Juan P Rodrigo; Julia A Woolgar; Alessandra Rinaldo; Asterios Triantafyllou; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-07       Impact factor: 2.503

7.  Proteasome regulation of ULBP1 transcription.

Authors:  James E Butler; Mikel B Moore; Steven R Presnell; Huei-Wei Chan; N Jan Chalupny; Charles T Lutz
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

Review 8.  ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications.

Authors:  Samantha A Armstrong; Christopher W Schultz; Ariana Azimi-Sadjadi; Jonathan R Brody; Michael J Pishvaian
Journal:  Mol Cancer Ther       Date:  2019-11       Impact factor: 6.261

Review 9.  The molecular pathogenesis of head and neck cancer.

Authors:  Jonah D Klein; Jennifer R Grandis
Journal:  Cancer Biol Ther       Date:  2010-01-09       Impact factor: 4.742

10.  Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome.

Authors:  Annette M Lim; Ida Lm Candiloro; Nicholas Wong; Marnie Collins; Hongdo Do; Elena A Takano; Christopher Angel; Richard J Young; June Corry; David Wiesenfeld; Stephen Kleid; Elizabeth Sigston; Bernard Lyons; Danny Rischin; Benjamin Solomon; Alexander Dobrovic
Journal:  Clin Epigenetics       Date:  2014-12-09       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.